Root Financial Partners
RLMD icon

Root Financial Partners’s Relmada Therapeutics RLMD Stock Holding History

Root Financial Partners’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$317 Buy
+84
New +$412 ﹤0.01% 3387

Other funds holding RLMD

Robertson Stephens Wealth Management
Robertson Stephens Wealth Management San Francisco, California $4.14B AUM 13.63% 1-Year Est. Return
CV Advisors
CV Advisors Aventura, Florida $594M AUM 18% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Root Financial Partners's RLMD Position: Q3 2026 in Review

Root Financial Partners opened a new position in Relmada Therapeutics (RLMD) in Q3 2026: 84 shares worth $317. The stake represents ﹤0.01% of the portfolio and ranks #3387 among its holdings.

7 funds tracked by Wall St. Rank hold RLMD as of Q3 2026.

  • Root Financial Partners held 84 shares of Relmada Therapeutics worth $317 as of Q3 2026.
  • Relmada Therapeutics was a new Root Financial Partners position in Q3 2026.
  • Relmada Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3387 holding.
  • 7 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.